Pharmaceutical agent for the treatment of myelogenous leukemia
CA 1297005 C · Owner: Hattori, Kunihiro · Inventors: Tamura, Masahiko; Hattori, Kunihiro
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention provides a pharmaceutical agent for the treatment of myelogenous leukemia that contains a human granulocyte colony stimulating factor (human G-CSF) as the effective ingredient. The pharmaceutical agent of the present invention is effective not only for increasing the number of peripheral mature neutrophiles in patients with myelogenous leukemia but also for prolonging their lives. Human G-CSFs which are suitable for use in a pharmaceutical agent of the present invention include ones obtained by isolation from the supernatant of the culture of a human G-CSF producing cell and a poly-, peptide or glycoprotein having G-CSF activity that is obtained by DNA recombinant …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Granted March 10, 1992. A Canadian patent filed before October 1, 1989 lasted 17 years from grant, so its term ended March 10, 2009.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.